Pharmaceuticals

Guobang Pharma Ltd. is a global, diversified pharmaceutical manufacturer with significant supply chain advantages and a complete industrial platform. We own 5 manufacturing sites, namely, Zhejiang Guobang Pharmaceutical, Shandong Guobang Pharmaceutical, Zhejiang Dongying Pharmaceutical, Xinchang Hebao Biotechnology and Zhejiang Zhongtong Pharmaceutical, covering more than 150 hectares of land for production and operational use.We hire more than 3000 employees and our products are sold to more than 110 countries and regions worldwide, benefiting a total population of 6.5 billion people.

Heranba Industries Ltd’ is one of the leading, listed & award winning company engaged in manufacturing & exporting Crop Protection, Animal Health, and Public Health Products from India. We have 4 Manufacturing units in the state of Gujarat (India) and having our Head Office & Marketing office in Mumbai (India). Over the last 20 years we have introduced comprehensive range of products & services taking care of Crop Protection, Animal Health, and Public Health. some of our products, like Deltamethrin & Alphacypermethrin are approved by WHO (World Health Organization) & export our products globally.

Hisun Pharma, founded in 1956, now is the one of the leading pharmaceutical manufactures in China. We are inspected by USFDA, EDQM, HPFB, TGA, APVMA, DCGI, etc.. We have broad portfolio of APIs including Oncology, Cardiovascular, Anti-infectives，Anti-parasitic, etc.

"Hubei Longxiang Pharmaceutical Tech.Co.,Ltd., was established in 2002, with registered capital RMB123 million. Now has 340 employees, total assets up to RMB440 million. Longxiang is the GMP certified, Key national high-tech enterprise, China's top 10 manufacturer for veterinary APIs. Specialized in R&D, producing and marketing of veterinary APIs and finished products. Toltrazuril、Florfenicol、Tilmicosin、Valnemulin HCL and other more than 20 APIs, have been exported to more than 40 countries and areas, like Europe, South America, East Asia, Southeast Asia, Middle East."

Livzon is a comprehensive pharmaceutical enterprise integrating development & research, production and sales of pharmaceutical products, ranking 9 at Top 50 Pharmaceutical companies in China, ranking 8 at Top 10 listed pharmaceutical companies with the highest R&D investment. Livzon Group API Division established June 2015, is dedicated in the R&D, manufacturing and sales of API, including 4 manufacturing sites, Livzon Fuzhou Fuxing, Livzon New North River, Livzon Ningxia and Livzon Syntpharm. Most of the manufacturing sites have been approved by US FDA. And most of the products in regulatory markets have obtained CEP.

Nantong Jinghua Pharmaceutical Co.,Ltd is a public pharmaceutical company in China that was established in 1957, owning about 302 staffs, located in No. 20, 3 Haibin Road, Yanhai Economic Development Zone, Rudong, Nantong Jiangsu, China. We are appointed as a high-new-technical enterprise by Jiangsu Scientific technological Bureau. As a comprehensive, advanced and innovative GMP company, we focus on manufacture, R&D and sales of APIs, pharmaceutical intermediates. Our company produce Phenobarbital, Primidone, Fluorouracil, Phenylbutazone, Flucytosine, Piroxicam, and Propylthiouracil etc., in which the first five products have CEP certificates.

Established in 1996, North China Pharmaceutical Group Aino Co., Ltd. is located in the Economic and Technical Development zone, Shijiazhuang, Hebei Province, P.R. China. During these years North China Pharmaceutical Group Aino Co., Ltd has been majoring in developing, manufacturing and selling green APIs. As Aino’s leading product, ABAMECTIN and IVERMECTIN are widely used as the most effective and broad-spectrum insecticides in the world. AINO produces strictly in accordance with GMP standards and become the first batch of China abamectin companies allowed to enter the United States and Europe market.

NCPC Huasheng is one of subsidiaries of NCPC. It was established in 1995, and production began in 1996. •More than 20 years dedicated in the manufacturing of APIs •Floor area: 85,000m2 •Personel: about 1,000peoples

NORTH CHINA PHARMACEUTICAL GROUP SEMISYNTECH CO., LTD is a wholly-owned subsidiary of NCPC, which is specialized in manufacturing and sales of penicillin series products including pharmaceutical intermediates and APIs. The company is located in economic & technical development zone of Liangcun, Shijiazhuang.

Shandong Shengli Bioengineering Co., Ltd is a joint venture built by China Animal Husbandry Industry Co., Ltd and Shandong Shengli Co., Ltd. We are national high-tech enterprise, and mainly producing animal-specific antibiotic API, veterinary preparations and feed additives, such as Tiamulin Fumarate, Enramycin, Bambermycin, Nosiheptide, and Monensin, etc. Shengli strictly follows the current GMP regulations in Europe and the United States, establishes a sound quality management system, and has passed ISO9001, ISO14001, ISO45001 certification, and the US FDA site audit with "0-483". Tiamulin Fumarate API is the first to obtain the EU COS Certificate in China, Enramycin is the first to obtain Production and Sale Certificate domestically. Based in China, with a global business strategy, the company has built a global marketing network.